Breast cancer cryoablation in combination with anti-CTLA-4 increases T cell activation in a murine tumor model

被引：0
|
作者：
de Miranda, Flavia Sardela [1 ]
Babcock, Rachel [1 ]
Castro, Maribel [1 ]
Khan, Sonia Y. [1 ]
Roach, Carsen [2 ]
Hintelmann, Thomas [1 ]
Furr, Kathryn [1 ]
Lee, Chang H. [2 ]
Boligala, Geetha P. [1 ]
Rasha, Fahmida [1 ]
Brandi, Luis [1 ]
Gill, Harvinder S. [2 ]
Pruitt, Kevin [1 ]
Rahman, Rakhshanda L. [1 ]
机构：
[1] Texas Tech Univ Hlth Sci Ctr, Lubbock, TX USA
[2] Texas Tech Univ, Lubbock, TX USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2022年 / 10卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B18
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An oral cancer vaccine using Bifidobacterium vector augments combination of anti-PD-1 and anti-CTLA-4 antibodies in mouse renal cell carcinoma model
    Ueki, Hideto
    Kitagawa, Koichi
    Kato, Mako
    Yanase, Shihoko
    Okamura, Yasuyoshi
    Bando, Yukari
    Hara, Takuto
    Terakawa, Tomoaki
    Furukawa, Junya
    Nakano, Yuzo
    Fujisawa, Masato
    Shirakawa, Toshiro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] A combination of lymphatic drug delivery of anti-CTLA-4 antibody and local radiotherapy for solid-tumor treatment
    Takagi, Koki
    Sukhbaatar, Ariunbuyan
    Inaba, Yohei
    Mori, Shiro
    Kodama, Tetsuya
    CANCER SCIENCE, 2024, 115 (12) : 4021 - 4033
  • [43] Combination of lactate dehydrogenase and tumor mutational burden to predict clinical benefit of anti-CTLA-4 therapy in melanoma
    Xiao, Wenjing
    Du, Nan
    Huang, Taoyuan
    Guo, Jinan
    Mo, Xing-kui
    Yuan, Tao
    Chen, Yong
    Ye, Ting
    Xu, Chunwei
    Wang, Wen xian
    Wang, Guoqiang
    Cai, Shangli
    Chen, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Synergistic antitumor effect of chemotactic-pro state tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model
    Li, Ning
    Qin, Hanjun
    Li, Xiaozhu
    Zhou, Chunxia
    Wang, Dongmei
    Ma, Wenbo
    Lin, Chen
    Zhang, Youhui
    Wang, Shengdian
    Zhang, Shuren
    IMMUNOLOGY LETTERS, 2007, 113 (02) : 90 - 98
  • [45] Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
    Wang, Bin
    Qin, Lei
    Ren, Mei
    Sun, Hao
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 260 - 270
  • [46] Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
    Peggs, Karl S.
    Quezada, Sergio A.
    Chambers, Cynthia A.
    Korman, Alan J.
    Allison, James P.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (08): : 1717 - 1725
  • [47] Anti-CTLA-4 Antibody Might Be Effective Against Non-small Cell Lung Cancer With Large Size Tumor
    Saijo, Hiroshi
    Hirohashi, Yoshihiko
    Honjo, Osamu
    Saikai, Toyohiro
    Shijubo, Naoki
    Takabatake, Hirotsugu
    Fujita, Akihisa
    Honda, Yasuhito
    Koba, Hiroyuki
    Chiba, Hirofumi
    Torigoe, Toshihiko
    ANTICANCER RESEARCH, 2023, 43 (09) : 4155 - 4160
  • [48] Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
    Kennedy, Paul T.
    Saulters, Emma L.
    Duckworth, Andrew D.
    Lim, Yeong Jer
    Woolley, John F.
    Slupsky, Joseph R.
    Cragg, Mark S.
    Ward, Frank J.
    Dahal, Lekh N.
    MOLECULAR THERAPY, 2024, 32 (02) : 457 - 468
  • [49] Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer
    Xia, Qiu
    Zhang, Fang-Fang
    Geng, Fei
    Liu, Chen-Lu
    Wang, Yu-Qian
    Xu, Ping
    Lu, Zhen-Zhen
    Xie, Yu
    Wu, Hui
    Chen, Yan
    Zhang, Yong
    Kong, Wei
    Yu, Xiang-Hui
    Zhang, Hai-Hong
    CELLULAR IMMUNOLOGY, 2016, 310 : 89 - 98
  • [50] Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
    Motoshima, Takanobu
    Komohara, Yoshihiro
    Horlad, Hasita
    Takeuchi, Ario
    Maeda, Yoshehiro
    Tanoue, Kenichiro
    Kawano, Yoshiaki
    Harada, Mamoru
    Takeya, Motohiro
    Eto, Masatoshi
    ONCOLOGY REPORTS, 2015, 33 (06) : 2947 - 2953
12345